Cyber Resilience Act guidance raises the stakes for connected product suppliers

Tern plc

The latest Cyber Resilience Act guidance makes the direction of travel clear for connected product manufacturers. Security now has to be built in from the start, maintained through the life of the product and backed by clear processes for risk management, vulnerability handling and ongoing support.

Companies can no longer treat security as a box-ticking exercise at launch. They need to show that products can stay secure after deployment, through updates, configuration changes, new integrations and extended use in the field. That raises the bar for execution and increases the importance of scalable security operations.

This is especially relevant in IoT and OT markets, where products often stay in service for years and depend on complex supply chains, third-party software and remote services. In that environment, weak processes create risk over time. Manual controls, fragmented systems and assumptions of trust become harder to defend when regulation expects continuous oversight.

Security decisions have to reflect how products work in the real world, including where they are deployed, what data they process, what systems they connect to and which threats they are likely to face. For businesses operating in connected-device markets, this points to the value of stronger device identity, trusted credentials and secure communications. Without those foundations, it becomes harder to enforce policy, manage updates securely or demonstrate that cyber risks are under control.

Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Tern increases convertible loan note investment in Talking Medicines

Tern has received £270,000 of new unsecured convertible loan notes from Talking Medicines, increasing its total convertible loan note holding to approximately £0.79 million while retaining a 23.8% equity stake.

Tern Plc invests $280,000 in Device Authority convertible loan notes

Tern has invested $280,000 in new unsecured convertible loan notes issued by Device Authority, forming part of a wider funding round of up to $1.6 million from existing investors.

Surgical training technology moves closer to the centre of precision medicine

Fundamental XR is targeting a critical adoption gap in advanced healthcare by using immersive simulation to help surgical teams prepare for complex procedures with greater consistency and scale.

GLP-1 therapies move into a wider investor debate

GLP-1 therapies are moving beyond weight loss and diabetes, creating a wider investor discussion around behaviour, risk and market positioning.

Tern raises £222,000 through share placing

Tern has raised £222,000 before expenses through a placing of 37 million new ordinary shares at 0.60 pence per share, with admission to AIM expected on or around 22 May 2026.

FundamentalXR targets surgical readiness for advanced eye therapies

FundamentalXR is targeting surgical readiness for advanced eye therapies with immersive simulation designed to support real-world adoption.

Search